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Background: Psoriasis is a chronic, inflammatory skin disease affecting approximately 2% of the UK population
and is currently incurable. It produces profound effects on psychological wellbeing and social functioning and has
significant associated co-morbidities. The majority of patients with psoriasis are managed in primary care, however
in-depth patient and GP perspectives about psoriasis management in this setting are absent from the literature.
This article reports an in-depth study which compares and contrasts the perspectives of people with psoriasis and
of GPs on the challenges of managing psoriasis in primary care.
Methods: In-depth, qualitative semi-structured interviews were conducted with a diverse sample of 29 people with
psoriasis and 14 GPs. Interviews were coded using principles of Framework Analysis to enable a comparison of
patient and practitioner perspectives on key issues and concepts arising from the data.
Results: Patients perceived GPs to be lacking in confidence in the assessment and management of psoriasis and
both groups felt lacking in knowledge and understanding about the condition. While practitioners recognised that
psoriasis has physical, emotional and social impact, they assumed patients had expertise in the condition and may
not address these issues in consultations. This resulted in patient dissatisfaction and sub-optimal assessment of
severity and impact of psoriasis by GPs. Patients and GPs recognised that psoriasis was not being managed as a
complex long-term condition, however this appeared less problematic for GPs than for patients who desired a
shared management with their GP incorporating appropriate monitoring and timely reviews.
Conclusions: The research suggests that current routine practice for psoriasis management in primary care is
mismatched with the expressed needs of patients. To address these needs, psoriasis must be recognised as a
complex long-term condition involving exacting physical, psychological and social demands, co-morbidity and
the development of new treatments.
General practitioners need to improve both their knowledge and skills in the assessment and management of
psoriasis. This in turn will facilitate management of the condition in partnership with patients. Commissioning
multi-disciplinary services, which focus on long-term impacts on wellbeing and quality of life, might address
current deficits in care.
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Psoriasis is a common, chronic and currently incurable
skin disease affecting at least 2% of the UK population
[1]. Many people live with psoriasis for the majority of
their adult lives [2,3]. High levels of chronic physical,
and psychosocial disability are reported [4-6], however
the visible nature of psoriasis can be particularly dis-
abling, with evidence of stigma, lowered self-image,
depression, anxiety and suicidal ideation [7], even in mild
psoriasis [8]. Co-morbidities include psoriatic arthritis [9],
Crohn’s disease [10] and in severe psoriasis, an increased
risk of cardiovascular disease (CVD) and of diabetes
[11,12].
People are dissatisfied with the management of their
psoriasis [13-17], and while recommendations have
emphasised the need for assessment to include an ob-
jective evaluation of severity and extent as well as the
patient’s subjective perception of impact [18], clinicians
do not routinely assess the impact of the condition upon
the individual [19]. Patients want their health care prac-
titioners to acknowledge, in consultations, the stress and
distress that often accompany living with psoriasis [20].
Additionally, low levels of medication adherence are prob-
lematic [21,22] and people may disengage from seeking
help from within the health service due to dissatisfaction
with care [20].
A recent collaboration between the Psoriasis Associ-
ation of Great Britain and Ireland and the Mental Health
Foundation [23] emphasises the need for people with
psoriasis to understand that help is available to address
its multi-faceted and long-term nature. In addition, the
report suggests that the new National Health Service
National Commissioning Board (NCB) should ensure that
all local health economies establish clear referral pathways
for psoriasis, with closely allied multi-disciplinary teams
who can address the complex nature of this long-term
condition (LTC). Long-term-conditions are increasingly
important determinants of quality of life and health care
costs in populations worldwide. Primary care is seen as
the optimal context to deliver care for people with LTCs
because it is accessible and efficient, with the emphasis on
‘shared management’ in which the general practitioner
(GP) supports patients in the self-management of their
condition [24].
The recently published National Institute for Health and
Clinical Excellence (NICE) Clinical Guideline for the
Assessment and Management of Psoriasis (CG 153) [25]
identifies that most people with psoriasis are managed in
primary care, although up to 60% may need referral to
specialist services at some point in their lives. The current
literature on healthcare practitioners’ perspectives of man-
aging psoriasis is sparse and focuses on the views of
dermatologists. Studies comparing dermatologists’ and
patients’ views about disease severity, impact on quality oflife and treatment goals report low levels of concordance
[26-28] with dermatologists describing psoriasis as a “frus-
trating” condition due to its incurability [29].
The experiences of people affected by psoriasis in
primary care or from the broader community have been
reported only rarely in the literature. Furthermore, and
despite the fact that most people with psoriasis will be
managed in this setting [10] the views of GPs are also
absent. This is of particular concern since GPs have a
key role in identifying, monitoring and helping to reduce
the risk of co-morbidities of psoriasis such as CVD and
depression [30]. To address these gaps, qualitative inter-
views with GPs and patients were undertaken which
enabled a comparison of views. This article reports an
in-depth study of the perspectives of people with psoria-
sis and of GPs on the challenges of managing psoriasis
in primary care.
Methods
The study was an in-depth, qualitative interview study
involving a community sample of people with psoriasis
and GPs in the North West of England. Approval was
obtained from the University of Manchester’s ethics com-
mittee for the patient and GP studies (Ref 10325 and Ref
11353 respectively) and from the Greater Manchester Pri-
mary Care Research Governance Partnership (ReGroup)
for the GP study (Ref 2011/280). Qualitative interviews
with patients and with GPs were conducted with prior
informed written consent from all participants.
Sampling and recruitment
Twenty-nine people with psoriasis were recruited by
placing poster advertisements in community venues
(libraries, community centres, places of religious worship,
shops and post offices) in Greater Manchester and via the
Psoriasis Association website (see Table 1 for advertise-
ment wording).
Twenty-six participants were from community sources
and three from the Psoriasis Association membership
list. Sampling was purposive for maximum variation
[31], on characteristics of sex, age, self-identified ethnic/
socio-economic background and self-identified severity
of psoriasis, duration and treatment (assessed by asking
participants to describe in their own words how severe
they perceived their psoriasis to be both currently and in
the past). Participants were interviewed at whatever
location was most convenient to them (own home, work-
place, community centre or university meeting room) over
the spring of 2011. Interviews were audio-recorded and
transcribed verbatim. This paper reports two of the
themes developed in the qualitative analysis. Other find-
ings based upon the patient interviews have been reported
elsewhere [20]. Seven GPs in urban/inner city practices
across each of three areas of Greater Manchester (north,
Table 1 Study advertisement wording
Headline information Contact details
Coping with Psoriasis If you would like to be interviewed
to express your views or if you
would like to find out more
please contact
Do you have psoriasis or
know someone who has?
(researcher) on:
(contact details)
We would like to learn from you
how psoriasis affects your life and
what helps you manage it so that
people with psoriasis can get better
care. This research is funded by the
NHS and is independent of any
commercial interests.
We will arrange to see you at a
time and place that is convenient
and can come to your home. If
you prefer to come to us we will
pay your travelling expenses.
Table 3 Patient demographics
Characteristic Female Male Totals
(24–72 years) (20–84 years)
14 15 29
Self-identified ethnicity
Bangladeshi 1 1 2
British Pakistani 0 1 1
Indian 1 4 5
Pakistani 2 0 2
Pakistani/European parents 1 0 1
White 9 9 18
Socio-economic background
Employment
Full-time work 3 7 10
Part-time work 3 3 6
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CAC-G and invited to take part in qualitative interviews
about psoriasis management. General practitioners from
14 of these practices were purposively sampled to achieve
a mixed sample in terms of gender, age, ethnicity, ‘type’ of
GP (eg. partner, salaried or trainee) and size of practice.
Interviews were conducted over the summer of 2012.
Data collection and analysis
Topic guides for both sets of interviews were developed
from the relevant literature (see Table 2).
Analysis began shortly after initial data collection,
using an iterative coding procedure in accordance with
principles of Framework Analysis, an analysis approach
appropriate to applied health services research, enabling
investigation of a priori issues while simultaneously
allowing for identification of newly emergent ideas in
the data [32]. For all interviews the progressing analysis
informed subsequent data collection. Transcripts under-
went preliminary coding by individual researchers with
core themes subsequently analysed by the team using
constant comparison within and across cases, with
attention to disconfirming cases and possible reasons for
differences. Sampling continued on both datasets until
main data categories were saturated and no new insights
were apparent [33]. Initial themes from the two datasets
were emergent, but in development of the paper, com-
parisons were made across the datasets and secondaryTable 2 Interview topic guides
Guide Topics
Patients Physical, emotional and social effects of psoriasis
Self-care strategies
Use of health services
Relationships with health care professionals
GPs Psoriasis management in primary care
GPs’ self-appraisal of their own management of
patients with psoriasisanalysis was carried out based on the recently published
NICE Guideline [25].
Results
Ninety people with psoriasis responded to advertising
and a varied sample of 29 was drawn to ensure diversity
(Table 3). Of 19 GPs invited to participate, 14 agreed to
be interviewed (Table 4).
From the perspectives of GPs and patients, two broad
themes, together with their sub-themes are presented.
These themes build on our prior published work on
patient perspectives [20], by comparing and contrasting
patient perspectives with those of GPs and linking the
findings to the recently published NICE Guideline
(CG153) [25].
The two themes presented are: 1) Assessing psoriasis
and being assessed, comprising views on the assessment
of psoriasis severity, its perceived impact on patients and
identification of psoriasis-associated co-morbidity and;
2) managing psoriasis as an LTC, comprising views on
information and advice, shared management, monitoring
and review and expertise and confidence. Broad themes
one and two from the analysis map respectively to the
dual elements of the recently published NICE GuidelineUnemployed 4 1 5
Full-time study 2 3 5
Retired 2 1 3
Self-identified psoriasis
severity
Severe 1 0 1
Moderate-severe 3 6 9
Moderate 3 2 5
Mild-moderate 6 4 10
Mild 1 3 4
Table 4 GP demographics
Characteristic Female Male Totals
5 9 14
Age
25–40 1 3 4
41–55 3 5 8
>55 1 1 2
Self-identified ethnicity
White British 4 6 10
White Other 0 2 2
Other 1 1 2
GP type
GP Partner 4 7 11
Salaried GP 0 1 1
GP trainee 1 1 2
Practice size
≤6000 (small) 2 5 7
>6000 (large) 3 4 7
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iasis (see Figure 1 for a diagrammatic representation of
the analytic themes and how they map to the NICE
Guideline elements).
The two broad analytic themes are now discussed,
with Illustrative data identified by patient or GP number
to support the analysis.MAPS TO NICE GUIDELINE KEY ELEMENT: 
‘ASSESSMENT’ OF PSORIASIS
THEME 1
Assessing psoriasis and 
being assessed
Sub-theme 1
Assessment of 
psoriasis severity 
& impact
Sub-theme 2
Identification of 
psoriasis-
associated co-
morbidity
Su
Info
Figure 1 Analytic themes mapping to key NICE guideline elements ‘aAssessing psoriasis and being assessed
There was variation in the disease models used by GPs
with some recognising psoriasis as a complex systemic
disease with a range of psychological, social and physical
sequelae. However most GP accounts described less
sophisticated clinical management approaches, reflecting
a model of psoriasis as a straightforward skin condition:
‘I think of it primarily as a skin complaint…
I am aware that there is…systemic problems…
but, I think in my own mind, I sometimes find it
difficult to put the two together’ (GP5)
By contrast, patients described psoriasis as a condition
affecting more than just skin, with exacting physical,
emotional and social consequences:
‘It’s a skin condition but it goes beyond that.
It doesn’t stay there. It sort of runs deeply…
there was discomfort on me. It got to the stage
where I was thinking about it so much I actually
cancelled meeting my friends’ (P17)Assessment of psoriasis severity and impact
The perspectives of patients and GPs differed in relation
to assessing the physical impact of psoriasis. Some GPs
described barriers to physical examination, including
feeling uncomfortable asking patients to undress, but
also reluctance to examine a condition that could beMAPS TO NICE GUIDELINE KEY ELEMENT: 
‘MANAGEMENT’ OF PSORIASIS
THEME 2
Managing psoriasis as a 
long-term condition
Sub-theme 2
Shared 
management, 
monitoring & 
review
Sub-theme 3
Expertise & 
confidence to 
manage psoriasis-
as a long-term 
condition
b-theme 1
rmation & 
advice
ssessment’ and ‘management’ of psoriasis.
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By contrast, patients wanted practitioners to engage in a
more thorough examination and discussion about their
condition:
‘[GP] has never looked…never examined me for
my skin…in six years or something like that’ (P8)‘I probably don’t examine them enough because
I look at what they show me…so I’ve never even
thought about the discussion…and well obviously
I feel uncomfortable undressing…’ (GP3)‘It can be quite distressing both for the patient…with
the kind of itching oozing scalp but it’s not the … most
pleasant thing in the world…to examine either’ (GP6)
Some GPs acknowledged that psoriasis may have an
adverse effect on people’s occupations and relationships,
seeing psoriasis as an extra stressor for patients who
have difficult lives already:
‘I think there’s something quite stigmatising about
psoriasis’ (GP5)‘I think skin conditions, because they’re “on the
surface”, produce an awful lot of worry in people’
(GP14)‘What makes it more difficult for [patient] is that
actually sleeping with his wife is not very pleasant
when he is really bad [during a flare]’ (GP2)
Patients concurred with these views by reporting that
appearance-related relationship issues were often of
most concern to them, however their accounts were
often graphic and emotionally charged, highlighting the
extent to which psoriasis could not only be bothersome
but distressing and socially disabling:
‘…people’s reactions, girls’ reactions…it’s your self-
consciousness of it. That could be quite overwhelming
at points’ (P1)‘Imagine trying to be sat somewhere with your nails
full of this stuff and it’s coming from your head and
your face and, kind of, interacting with people is
really, really hard’ (P20)
Despite recognition of the possible emotional and social
effects of psoriasis, several GPs minimised its emotional
impact, losing the opportunity for more focused assess-
ment and discussion of wellbeing. By contrast, many pa-
tients described their frustration and disappointment thatwithin consultations their GPs had not explored the wider
impact of psoriasis:
‘I haven’t got any patients who are distressed to the
point of not wanting to go out, not wanting to do
anything, where it impacts on their lives…mostly
because I think we manage their psoriasis sufficiently
well’ (GP10)‘You don’t really get a chance to express yourself.
I’ve not been to hospital yet with [psoriasis],
so I don’t know if somebody is going to be able to
listen to what is actually going on for me.
I kind of, feel embarrassed going out. There’s no
one listening to that’ (P20)
Identification of psoriasis-associated co-morbidity
While some GPs identified that depression could be
more common in patients with psoriasis, many reported
that depression was so prevalent in all their population
it was difficult to assess its relationship with the condi-
tion. Patients by contrast often referred to psoriasis as
depressing:
‘40% of our patients take an antidepressant…
so should we just ask everyone [with psoriasis]
“do you feel sad?”’ (GP2)‘I don’t know why but I got in this really deep
depression…all the dry skin and it’s so dry…and
I did feel…I went home and I couldn’t stand it’ (P14)
Most GPs were aware that psoriatic arthritis was a co-
morbidity, but fewer recognised possible links with CVD
risk. In common with depression, GPs did not routinely
case-find for CVD, citing perceived low mortality and
prevalence of psoriasis as a barrier to screening. Patients
were commonly unaware of the possible CVD risk
conferred by psoriasis:
‘…the main aspect is that [patients] are pretty unlikely
to die from psoriasis…it’s not going to predispose them
to other major problems…unless they get psoriatic
arthropathy’ (GP4)‘Not that I know of [co-morbidities other than psoriatic
arthritis]. I’ve not been told anything, unless a surprise
is waiting for me when I go to see the dermatologist’
(P16)
General Practitioners recognised that psoriasis could
be a demanding condition with impact on patients’
emotional wellbeing and quality of life, however they
were less likely to undertake structured assessments
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or possible co-morbidities.
Managing psoriasis as an LTC
Information and advice
General Practitioners recognised psoriasis as an LTC
due to its chronicity, but its management was not com-
parable to that of other LTCs. While patients believed
that information from their GPs about their condition
was lacking, GPs suggested patients did not actively seek
information about their psoriasis. Some commented that
this may be an area they should address:
‘I think patients often want to know more…than GPs
tell them…so they probably want to know more than
maybe they’re asking’ (GP12)‘[GP] did not give me information, or didn’t sort of
think it was important’ (P18)
Many patients reported that they managed their
psoriasis in isolation from their GP and in the absence
of adequate information and advice, often with signifi-
cant levels of uncertainty about prescribed treatments
(or need for a different level of treatment). In contrast,
some of the GPs stressed the patients’ responsibility for
managing psoriasis treatments particularly in terms of
persistence:
‘I get fed up…you can use [creams] for a period of time
but eventually they stop working…my psoriasis will
keep growing and the cream will lose its effect. So I
generally don’t put anything on my skin’ (P8)‘..so much of the success of psoriasis treatments is
based on patients’ ability to manage it themselves and
apply stuff appropriately…we can prescribe anything
we like but if the patient isn’t using it correctly it’s
probably not going to work’ (GP11)
Shared management, monitoring and review
Patients described the need for continuity with their
GP to plan management of their condition, but felt
this was not offered. Conversely, GPs considered
responsibility for re-attending to lie with patients,
being undecided about whether patients wanted to be
followed up:
‘There was never any kind of follow-up to it and I
never went to the GP for any other reason, over the
10-year period’ (P11)‘Patients’ willingness and desire to be regularly
reviewed is very variable. A lot of them, even if you saycome back in a month…they don’t come back, they
don’t really want to see you again’ (GP8)
Some patients reported that their own knowledge and
experience were not explored or valued by practitioners,
with limited opportunity to negotiate management plans:
‘GPs, will do as much as they can with what they're
allowed to give you, but if it doesn't work then it's just
a case of…“well, that's all that's available”’ (P16)
This corresponded with the GP accounts. There was
little evidence that on-going, shared management in
psoriasis was something they did routinely. Only one GP
raised the issue of negotiating treatment goals with
patients:
‘Perhaps I don’t ask enough about what their
treatment goals are…we all have our own assumptions
about what a good outcome is and we don’t
necessarily share that with patients’ (GP5)
For LTCs that are included in the UK Quality and
Outcomes Framework (QOF) [34], recall systems oper-
ate to invite patients for regular review. Psoriasis is
currently not included in QOF, and GPs reported that
review and recall were not organised for people with
psoriasis:
‘The difference [compared to other LTCs] is
that our systems will pick up a lot of the other ones…
and we’ll end up chasing them…because of the
way we’re paid through QOF…we’ve got an
incentive to manage a certain group of chronic
diseases but with other ones there isn’t the same
kind of incentives…so you don’t get the systems
in to …chase them’ (GP7)
This discrepancy did not go unnoticed by patients with
other conditions and for whom this apparent lack of
attention to their psoriasis was a source of dissatisfaction:
‘Big difference [between psoriasis care and other
LTC care]…because of my heart problems
and the medication I’m on, they’ve given me a
lot of time’ (P20)
Many patients were consequently not in regular con-
tact with their primary care providers and were often
coping sub-optimally with their psoriasis, believing that
little could be done to help. By contrast, GPs often
assumed that when patients did not return for review,
they were not experiencing problems but rather were
coping well:
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just worse and worse and worse…might be a slight
improvement, but the general trend…it is very
depressing’ (P1)‘I think some [patients] just think “oh well, it’s
not so bad at the moment I won’t bother”…
or some of them just get repeat prescriptions for
something they like’ (GP8)
Within consultations, addressing lifestyle issues in
relation to psoriasis triggers, exacerbation or increased
CV risk did not appear to be prioritised by GPs. With
the exception of alcohol, GPs referred to few lifestyle
factors as important in psoriasis management. Patients
too suggested that discussion of lifestyle did not rou-
tinely take place in consultations with GPs:
‘Alcohol can make [psoriasis] worse but not much else’
(GP12)‘I’ve had pretty much no advice other than – let’s try
this treatment. So no lifestyle advice or anything like
that’ (P1)
Expertise and confidence to manage psoriasis as an LTC
Most GP accounts indicated low levels of expertise and
confidence in the management of people with psoriasis,
blaming lack of undergraduate and postgraduate training
in dermatology. Patients also perceived GPs to be lack-
ing in knowledge and expertise:
‘There wasn’t a huge amount of dermatology
[training]…I would probably do more if I knew
more’ (GP9)‘GPs just basically didn’t know what to do with it
because they don’t come across it, or if they do come
across it they have limited knowledge of it’ (P6)
Some GPs deferred to their patients as having greater
knowledge, and viewed them as experts in their condi-
tion, particularly in terms of their experiences of treat-
ments tried and failed:
‘People with psoriasis are experienced, they know
about their illness…it’s no good saying “here’s a
treatment” if they say “yeah, I tried that and I really
hated it” or “it smelled”’ (GP8)
In contrast, several of the patient accounts referred to
low levels of confidence or knowledge about psoriasis,
particularly in terms of causes, triggers, how to manage
symptoms, and wanting expert advice:‘I don’t know what causes it to be like this.
I have oily fish, I eat fish twice aweek. I try to eat
healthy. I use the creams which they say. Nothing
seems to calm it down. It just flares up and that’s it.
Over the years it has got worse and what’s going to
happen in a bit?’ (P12)
General Practitioners acknowledged difficulties mana-
ging a condition that did not seem to respond to their
input. This mirrored the accounts of patients who be-
lieved there was little a GP could do to help with psoriasis
and were consequently reluctant to consult:
‘[Patient] does have this chronic condition that’s been
very difficult to manage over the years and … I often
feel a little bit helpless trying to … help’ (GP6)‘I should have gone to my GP about [psoriasis], but…I
was just under the general impression that there was
very little they could do’ (P11)
General Practitioners and patients concurred on the
perceived lack of shared management of psoriasis and that
the condition was not subject to the same level care as
other LTCs. Specifically, shared management of patients’
needs for information and support for medications mana-
gement, self-care and coping was problematic. Systems for
adequate monitoring and review were lacking.
Discussion
Summary of main findings
This is the first article to present the perspectives of
people with psoriasis alongside those of GPs about
management of the condition in primary care. While
patients may sense practitioners’ lack of confidence in
the assessment and management of psoriasis and GPs
may mistakenly assume that patients possess expertise in
their condition, both feel that they are lacking in know-
ledge and understanding of psoriasis. Practitioners rec-
ognise that psoriasis may have physical, emotional and
social impacts but report circumventing discussion of
these in consultations, which may result in sub-optimal
assessment of severity and impact. In contrast, patients
reported them as disabling and would welcome oppor-
tunities to discuss them. Patients and GPs concur on the
lack of management of psoriasis as an LTC, however this
appears less problematic for GPs than for patients, who
desire appropriate review and monitoring.
Comparison with previous literature
The previous literature demonstrates that psoriasis is de-
manding to live with [20,35] and that dissatisfaction with
care exists among patients [15,20] whose views on psoria-
sis management may differ from those of dermatologists
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highlight the contrasts in the perspectives of psoriasis
patients and GPs and suggests reasons for the low number
of primary care consultations by patients [36]. This
research offers a more nuanced understanding of the mis-
match between practitioner and patient views, highlight-
ing factors which may contribute to patients’ perceived
difficulties with understanding and appropriately man-
aging their psoriasis and the lack of shared management
of psoriasis as an LTC in primary care [37].
The 2012 NICE Guideline for psoriasis [25] recognises
primary care as the context in which the vast majority of
psoriasis patients are managed, stressing the significant
impact that all aspects of psoriasis have on wellbeing.
This underlines the need to adopt a broader approach to
the management of psoriasis which integrates physical
and emotional approaches to care. Such an approach
would include adequate assessment of all aspects of the
condition, comprising objective assessment of the extent
and severity, as well as the patient’s own perception of
impact, prompt, effective treatment and long-term dis-
ease control including discussion of lifestyle support and
appropriate referral. The narrow view expressed by some
GPs in this study suggests that there are gaps in know-
ledge, skills and training that need to be addressed.
Strengths and limitations
The patient sample was diverse. Recruiting from the
community may have enabled participants to give more
candid accounts of their relationships with professionals.
This could however, lead to a self-selection bias with the
most dissatisfied people responding to advertising. The
practitioner sample was relatively small, most being
white British GP partners, and may not be representative
of the views of GPs in the UK as a whole. However the
data illustrate an important perspective on the manage-
ment of psoriasis in primary care, which is currently
absent from the literature. Data analysis benefited from
the perspectives of professionals from a breadth of
backgrounds including dermatology, primary care, health
psychology and health services research [38].
Implications for clinical practice and future research
Understanding and recognition of psoriasis as a complex
LTC involving significant psychosocial impact, co-
morbidity and the development of new treatments [39]
has so far not extended to primary care where current
routine practice is misaligned with the expressed needs
of patients. The study was conducted before the NICE
Guideline [25] was published and this of itself may raise
GPs’ awareness of the complexity of psoriasis and the
need to assess and manage psoriasis patients as they
would do those with other LTCs. Thus, they would
develop systems for on-going monitoring and management[40]. Psoriasis care is currently not incentivised under QOF
[34], limiting the likelihood of GPs setting up disease
registers and recall systems for psoriasis [41]. In addition,
viewing psoriasis as a simple condition means that GPs
may not provide patients with adequate opportunities to
discuss their concerns. Experiences of such consultations
may recursively discourage consulting about psoriasis,
with adverse consequences for self-care and coping in-
cluding adherence to prescribed medications. Better
knowledge, understanding and training about psoriasis
among GPs is needed, as well as improved consultation
skills to enable management of the condition in partner-
ship with patients.
Conclusion
The importance of routine assessment of psoriasis in
primary care was highlighted in recent guidance [25].
General practitioners should systematically record levels
of psoriasis severity which contain an indicator of impact
of the condition on their patients. Furthermore, the
recent report by the Mental Health Foundation in colla-
boration with the Psoriasis Association [23] emphasises
the need for multi-disciplinary services which address
long-term impact on psychological wellbeing and quality
of life. The challenge facing the NCB and Clinical
Commissioning Groups will be to configure services
which recognise psoriasis as a LTC, requiring systems of
monitoring and integrated bio-psychosocial support
similar to other LTCs, and with appropriate referral
pathways for patients when more specialist help is
needed. The current downward pressure on referrals as
operationalized by the Quality and Productivity indica-
tors in QOF [42] may act as a barrier to the develop-
ment of such pathways for psoriasis if it continues to be
seen primarily as a skin condition.
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